Security key
88032L605
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX)
CUSIP: 88032L605
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 26,414,314
- Total 13F shares
- 2,231,961
- Share change
- +225,539
- Total reported value
- $12,926,914
- Price per share
- $5.76
- Number of holders
- 25
- Value change
- +$1,314,380
- Number of buys
- 8
- Number of sells
- 4
Report period
Q2 2025
Institutions
25
Top holders
10
TENX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
TENAX THERAPEUTICS, INC. SEC filings
TENAX THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88032L605
Recent filing periods:
Top shareholders of TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vestal Point Capital, LP |
13D/G
13F
|
Company |
9.9%
|
2,470,096
|
$18,525,720 | $0 | 30 Sep 2024 | |
| S.H.N. Financial Investments Ltd. |
13D/G
|
— |
5%
|
179,050
|
$1,052,814 | $0 | 31 Dec 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.4%
|
378,346
|
$2,478,166 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
1.3%
|
339,549
|
$2,224,046 | — | 31 Mar 2025 | |
| Venrock Adviser, LLC |
13F
|
Company |
0.79%
|
208,333
|
$1,364,581 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
0.79%
|
208,333
|
$1,364,581 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.63%
|
167,000
|
$1,093,850 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.63%
|
166,666
|
$1,060,829 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
121,094
|
$793,166 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.32%
|
83,333
|
$545,831 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.32%
|
83,333
|
$545,831 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.26%
|
68,741
|
$450,254 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
33,341
|
$218,383 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
26,626
|
$174,400 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
23,141
|
$151,574 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.08%
|
22,287
|
$145,980 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
19,243
|
$126,042 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,893
|
$18,950 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
300
|
$1,965 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
229
|
$1,500 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
192
|
$1,258 | — | 31 Mar 2025 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1
|
$7 | — | 31 Mar 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
1
|
$6 | — | 31 Mar 2025 | |
| Union Bancaire Privee, UBP SA |
13F
|
Company |
0%
|
1
|
$6 | — | 31 Mar 2025 | |
| Dellora Investments LP |
3/4/5
|
no longer 10% owner |
—
class O/S missing
|
351,071
|
— | — | 05 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
3/4/5
|
Director |
—
mixed-class rows
|
31,213,785
mixed-class rows
|
— | — | 18 May 2022 | |
| Anthony A. DiTonno |
3/4/5
|
CEO, Director |
—
class O/S missing
|
50,000
|
— | — | 06 Jul 2021 | |
| James P. Mitchum |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
— | — | 10 Jun 2021 |
Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) as of Q2 2025
As of 30 Jun 2025,
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,231,961 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, Vivo Capital, LLC, MORGAN STANLEY, Integral Health Asset Management, LLC, JANUS HENDERSON GROUP PLC, ADAR1 Capital Management, LLC, VR ADVISER, LLC, and Velan Capital Investment Management LP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
23
Q2 2025 holders
25
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.